Funding · Company
Lenz Therapeutics, Inc.
Del Mar, CABiotech & Pharma
Lenz Therapeutics, Inc. of Del Mar, CA has disclosed $133M across 2 Form D offerings filed with the SEC between Nov 22, 2022 and Mar 10, 2023.
$133M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersDel Mar, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001678518Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →